Literature DB >> 10807590

Novel biochemical and functional insights into nuclear Ca(2+) transport through IP(3)Rs and RyRs in osteoblasts.

O A Adebanjo1, G Biswas, B S Moonga, H K Anandatheerthavarada, L Sun, P J Bevis, B R Sodam, F A Lai, N G Avadhani, M Zaidi.   

Abstract

We report the first biochemical and functional characterization of inositol trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs) in the nuclear membrane of bone-forming (MC3T3-E1) osteoblasts. Intact nuclei fluoresced intensely with anti-RyR (Ab(34)) and anti-IP(3)R (Ab(40)) antisera in a typically peripheral nuclear membrane pattern. Isolated nuclear membranes were next subjected to SDS-PAGE and blotted with isoform-specific anti-receptor antisera, notably Ab(40), anti-RyR-1, anti-RyR-2 (Ab(129)), and anti-RyR-3 (Ab(180)). Only anti-RyR-1 and Ab(40) showed bands corresponding, respectively, to full-length RyR-1 ( approximately 500 kDa) and IP(3)R-1 (approximately 250 kDa). Band intensity was reduced by just approximately 20% after brief tryptic proteolysis of intact nuclei; this confirmed that isolated nuclear membranes were mostly free of endoplasmic reticular contaminants. Finally, the nucleoplasmic Ca(2+) concentration ([Ca(2+)](np)) was measured in single nuclei by using fura-dextran. The nuclear envelope was initially loaded with Ca(2+) via Ca(2+)-ATPase activation (1 mM ATP and approximately 100 nM Ca(2+)). Adequate Ca(2+) loading was next confirmed by imaging the nuclear envelope (and nucleoplasm). Exposure of Ca(2+)-loaded nuclei to IP(3) or cADP ribose resulted in a rapid and sustained [Ca(2+)](np) elevation. Taken together, the results provide complementary evidence for nucleoplasmic Ca(2+) influx in osteoblasts through nuclear membrane-resident IP(3)Rs and RyRs. Our findings may conceivably explain the direct regulation of osteoblastic gene expression by hormones that use the IP(3)-Ca(2+) pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807590     DOI: 10.1152/ajprenal.2000.278.5.F784

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

1.  Patch-clamp electrophysiology of intracellular Ca2+ channels.

Authors:  Don-On Daniel Mak; Horia Vais; King-Ho Cheung; J Kevin Foskett
Journal:  Cold Spring Harb Protoc       Date:  2013-09-01

2.  Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor.

Authors:  Adriana Di Benedetto; Li Sun; Carlo G Zambonin; Roberto Tamma; Beatrice Nico; Cosima D Calvano; Graziana Colaianni; Yaoting Ji; Giorgio Mori; Maria Grano; Ping Lu; Silvia Colucci; Tony Yuen; Maria I New; Alberta Zallone; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

Review 3.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

4.  NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors.

Authors:  Julia V Gerasimenko; Yoshio Maruyama; Kojiro Yano; Nick J Dolman; Alexei V Tepikin; Ole H Petersen; Oleg V Gerasimenko
Journal:  J Cell Biol       Date:  2003-10-20       Impact factor: 10.539

5.  Absence of the ER Cation Channel TMEM38B/TRIC-B Disrupts Intracellular Calcium Homeostasis and Dysregulates Collagen Synthesis in Recessive Osteogenesis Imperfecta.

Authors:  Wayne A Cabral; Masaki Ishikawa; Matthias Garten; Elena N Makareeva; Brandi M Sargent; MaryAnn Weis; Aileen M Barnes; Emma A Webb; Nicholas J Shaw; Leena Ala-Kokko; Felicitas L Lacbawan; Wolfgang Högler; Sergey Leikin; Paul S Blank; Joshua Zimmerberg; David R Eyre; Yoshihiko Yamada; Joan C Marini
Journal:  PLoS Genet       Date:  2016-07-21       Impact factor: 5.917

6.  NR1 and NR3B Composed Intranuclear N-methyl-d-aspartate Receptor Complexes in Human Melanoma Cells.

Authors:  Tibor Hajdú; Tamás Juhász; Csilla Szűcs-Somogyi; Kálmán Rácz; Róza Zákány
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.